We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$4.21B
AUM Growth
+$1.09B
(+35%)
Cap. Flow
+$955M
Cap. Flow
% of AUM
22.68%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$110M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$47.6M |
| 3 |
Apple
AAPL
|
+$45.5M |
| 4 |
Microsoft
MSFT
|
+$37.2M |
| 5 |
Amazon
AMZN
|
+$33.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$15.9M |
| 2 |
Caterpillar
CAT
|
+$8.11M |
| 3 |
Golub Capital BDC
GBDC
|
+$7.53M |
| 4 |
Intel
INTC
|
+$6.76M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$6.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.98% |
| 2 | Industrials | 11.87% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.53% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.13B
| $441K | 0.01% |
3,436
-22
| -0.6% | -$2.79K |
|
477
AstraZeneca
AZN
$269B
| $438K | 0.01% |
4,409
-4,444
| -50% | -$447K |
|
478
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5B
| $435K | 0.01% |
5,064
-1,458
| -22% | -$124K |
|
479
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $435K | 0.01% |
+5,248
| New | +$463K |
|
480
Regions Financial
RF
$26.4B
| $433K | 0.01% |
20,979
-15,671
| -43% | -$306K |
|
481
Trade Desk
TTD
$8.97B
| $427K | 0.01% |
+6,560
| New | +$507K |
|
482
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
| $423K | 0.01% |
7,930
+1,397
| +21% | +$75.2K |
|
483
Campbell Soup
CPB
$6.85B
| $421K | 0.01% |
8,366
+28
| +0.3% | +$1.33K |
|
484
Alerian MLP ETF
AMLP
$12.9B
| $417K | 0.01% |
13,664
+506
| +4% | +$14.8K |
|
|
IBDM
485
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
| $414K | 0.01% |
+16,665
| New | +$414K |
|
486
Alaska Air
ALK
$5.11B
| $413K | 0.01% |
5,973
+219
| +4% | +$13.2K |
|
487
Electronic Arts
EA
$52.7B
| $409K | 0.01% |
3,023
-4
| -0.1% | -$554 |
|
488
Markel Group
MKL
$25.2B
| $405K | 0.01% |
355
-53
| -13% | -$57.2K |
|
489
iShares MSCI KLD 400 Social ETF
DSI
$5.1B
| $404K | 0.01% |
5,286
| – | – |
|
490
iShares Morningstar US Equity ETF
ILCB
$1.24B
| $403K | 0.01% |
7,188
| – | – |
|
491
Keysight
KEYS
$50.7B
| $401K | 0.01% |
2,798
+14
| +0.5% | +$1.99K |
|
492
ConocoPhillips
COP
$144B
| $396K | 0.01% |
7,472
+115
| +2% | +$5.67K |
|
493
Nutanix
NTNX
$16.1B
| $390K | 0.01% |
14,700
-2,329
| -14% | -$70.8K |
|
494
Allstate
ALL
$70.6B
| $389K | 0.01% |
3,383
+651
| +24% | +$71.7K |
|
495
Compass Diversified
CODI
$752M
| $387K | 0.01% |
16,716
-30
| -0.2% | -$675 |
|
496
Globant
GLOB
$1.65B
| $387K | 0.01% |
+1,862
| New | +$395K |
|
497
Las Vegas Sands
LVS
$31.4B
| $383K | 0.01% |
+6,311
| New | +$369K |
|
498
Neurogene
NGNE
$672M
| $382K | 0.01% |
+1,550
| New | +$396K |
|
499
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $382K | 0.01% |
9,947
-124
| -1% | -$4.7K |
|
500
Broadstone Net Lease
BNL
$4.25B
| $378K | 0.01% |
+20,650
| New | +$381K |
|
Similar funds
Cerity Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Cerity Partners held 765 positions worth $4.21B, up 35% from $3.12B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cerity Partners deployed $955M of net new capital in Q1 2021, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was Allogene Therapeutics: 401,602 shares worth $14.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Caterpillar, an estimated $8.11M trimmed.
- Cerity Partners's largest Q1 2021 buy was Allogene Therapeutics: 401,602 shares worth $14.2M.
- Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $110M increase.
- Cerity Partners's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $8.11M.
- Cerity Partners fully exited Cantel Medical Corporation in Q1 2021, selling an estimated $15.9M.
- Cerity Partners's ten largest holdings make up 34% of its $4.21B portfolio in Q1 2021.
- Cerity Partners opened 125 new positions and closed 72 in Q1 2021.
- Cerity Partners's portfolio value rose 35% quarter-over-quarter to $4.21B.
Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.